• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估暴露于基于脂质的纳米颗粒下的成纤维细胞的细胞毒性:一种高内涵分析方法。

Assessing cellular toxicities in fibroblasts upon exposure to lipid-based nanoparticles: a high content analysis approach.

机构信息

Cell Screening Facility for Personalized Medicine, Laboratory for Neurodegenerative Diseases and Personalized Medicine, Tel Aviv University, Tel Aviv 69978, Israel.

出版信息

Nanotechnology. 2011 Dec 9;22(49):494016. doi: 10.1088/0957-4484/22/49/494016. Epub 2011 Nov 21.

DOI:10.1088/0957-4484/22/49/494016
PMID:22101838
Abstract

Lipid-based nanoparticles (LNPs) are widely used for the delivery of drugs and nucleic acids. Although most of them are considered safe, there is confusing evidence in the literature regarding their potential cellular toxicities. Moreover, little is known about the recovery process cells undergo after a cytotoxic insult. We have previously studied the systemic effects of common LNPs with different surface charge (cationic, anionic, neutral) and revealed that positively charged LNPs ((+)LNPs) activate pro-inflammatory cytokines and induce interferon response by acting as an agonist of Toll-like receptor 4 on immune cells. In this study, we focused on the response of human fibroblasts exposed to LNPs and their cellular recovery process. To this end, we used image-based high content analysis (HCA). Using this strategy, we were able to show simultaneously, in several intracellular parameters, that fibroblasts can recover from the cytotoxic effects of (+)LNPs. The use of HCA opens new avenues in understanding cellular response and nanotoxicity and may become a valuable tool for screening safe materials for drug delivery and tissue engineering.

摘要

基于脂质的纳米颗粒(LNPs)被广泛用于药物和核酸的递释。尽管大多数 LNPs 被认为是安全的,但文献中关于其潜在细胞毒性的证据令人困惑。此外,人们对细胞在受到细胞毒性损伤后的恢复过程知之甚少。我们之前研究了具有不同表面电荷(阳离子、阴离子、中性)的常见 LNPs 的全身效应,结果表明,带正电荷的 LNPs((+)LNPs) 通过作为 Toll 样受体 4 的激动剂在免疫细胞上发挥作用,激活促炎细胞因子并诱导干扰素反应。在这项研究中,我们专注于暴露于 LNPs 的人成纤维细胞的反应及其细胞恢复过程。为此,我们使用基于图像的高通量分析(HCA)。使用这种策略,我们能够同时在几个细胞内参数中显示,成纤维细胞可以从(+)LNPs 的细胞毒性作用中恢复。HCA 的使用为理解细胞反应和纳米毒性开辟了新途径,并且可能成为筛选用于药物递送和组织工程的安全材料的有价值工具。

相似文献

1
Assessing cellular toxicities in fibroblasts upon exposure to lipid-based nanoparticles: a high content analysis approach.评估暴露于基于脂质的纳米颗粒下的成纤维细胞的细胞毒性:一种高内涵分析方法。
Nanotechnology. 2011 Dec 9;22(49):494016. doi: 10.1088/0957-4484/22/49/494016. Epub 2011 Nov 21.
2
The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation.正电脂质纳米颗粒的全身毒性及 Toll 样受体 4 在免疫激活中的作用。
Biomaterials. 2010 Sep;31(26):6867-75. doi: 10.1016/j.biomaterials.2010.05.027. Epub 2010 Jun 11.
3
Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.两性霉素B包封脂质纳米粒及其体外和体内特性。
Eur J Pharm Sci. 2009 Jun 28;37(3-4):313-20. doi: 10.1016/j.ejps.2009.02.021. Epub 2009 Mar 13.
4
The physical state of lipid nanoparticles influences their effect on in vitro cell viability.脂质纳米粒的物理状态会影响它们对体外细胞活力的影响。
Eur J Pharm Biopharm. 2011 Sep;79(1):150-61. doi: 10.1016/j.ejpb.2011.03.022. Epub 2011 Mar 31.
5
Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells.透明质酸接枝脂质体纳米颗粒作为癌症细胞的 RNAi 载体。
Cancer Lett. 2013 Jul 1;334(2):221-7. doi: 10.1016/j.canlet.2012.08.024. Epub 2012 Aug 27.
6
Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement.将液态脂质纳入脂质纳米粒以增强眼部药物传递。
Nanotechnology. 2010 Jan 15;21(2):025101. doi: 10.1088/0957-4484/21/2/025101. Epub 2009 Dec 3.
7
Immunotoxicity derived from manipulating leukocytes with lipid-based nanoparticles.基于脂质的纳米粒子操纵白细胞导致的免疫毒性。
Adv Drug Deliv Rev. 2012 Dec;64(15):1738-48. doi: 10.1016/j.addr.2012.06.013. Epub 2012 Jul 20.
8
A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung.吸入式固体脂质纳米粒作为肺部潜在药物传递系统的毒理学评价
Eur J Pharm Biopharm. 2010 Jun;75(2):107-16. doi: 10.1016/j.ejpb.2010.02.014. Epub 2010 Mar 3.
9
Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.癌症的纳米医学:用于药物递送和监测的基于脂质的纳米结构。
Acc Chem Res. 2011 Oct 18;44(10):1080-93. doi: 10.1021/ar200011r. Epub 2011 Jul 26.
10
Altering the immune response with lipid-based nanoparticles.利用基于脂质的纳米粒子改变免疫反应。
J Control Release. 2012 Jul 20;161(2):600-8. doi: 10.1016/j.jconrel.2011.12.034. Epub 2011 Dec 30.

引用本文的文献

1
Noncoding RNAs in cancer therapy resistance and targeted drug development.非编码 RNA 在癌症治疗耐药性和靶向药物研发中的作用。
J Hematol Oncol. 2019 Jun 7;12(1):55. doi: 10.1186/s13045-019-0748-z.
2
Local Delivery of , , and mRNA Kindles Global Anticancer Immunity.局部递送 、 、 和 mRNA 引发全身性抗癌免疫。
Cancer Res. 2019 Apr 1;79(7):1624-1634. doi: 10.1158/0008-5472.CAN-18-2867. Epub 2019 Jan 28.
3
A novel image-based high-throughput screening assay discovers therapeutic candidates for adult polyglucosan body disease.
一种基于图像的新型高通量筛选检测方法发现了成人多糖体病的治疗候选药物。
Biochem J. 2017 Sep 28;474(20):3403-3420. doi: 10.1042/BCJ20170469.
4
Convergence of Highly Resolved and Rapid Screening Platforms with Dynamically Engineered, Cell Phenotype-Prescriptive Biomaterials.高度解析且快速筛选平台与动态工程化、细胞表型规定性生物材料的融合。
Curr Pharmacol Rep. 2016 Jun;2(3):142-151. doi: 10.1007/s40495-016-0057-y. Epub 2016 Mar 18.
5
Radiofrequency treatment alters cancer cell phenotype.射频治疗会改变癌细胞表型。
Sci Rep. 2015 Jul 13;5:12083. doi: 10.1038/srep12083.
6
Harnessing RNAi nanomedicine for precision therapy.利用RNA干扰纳米药物进行精准治疗。
Mol Cell Ther. 2014 Feb 5;2:5. doi: 10.1186/2052-8426-2-5. eCollection 2014.
7
Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?流感疫苗接种中佐剂的特性与前景——是棘手的沉淀物还是天赐良机?
Mol Cell Ther. 2013 Nov 6;1:2. doi: 10.1186/2052-8426-1-2. eCollection 2013.